AYYC received consulting/speaking honoraria from Abbott, AstraZeneca, Amgen, Bayer, Boehringer Ingelheim, Dexcom, Eli Lilly, GSK, HLS Therapeutics, Insulet, Janssen, Medtronic, Novo Nordisk, Pfizer, Sanofi, and Vertex
Be cautious, monitor patients closely, review entire medication lists, and do frequent lab checks when initiating peptides
Semaglutide and other GLP-1 medications are typically considered for individuals who: Have struggled to lose weight through diet and exercise alone Are committed to making sustainable lifestyle changes Are seeking to improve metabolic health under medical guidance Are overweight and have weight-related health conditions Have obesity Have a body mass index (BMI) of 30 or higher GLP-1 Weight Loss: What to Expect As with any medication, the effect of GLP-1 medication varies from patient to patient
J., Bessesen, D
No inducement to be offered 164
What needle gauge is listed